GCSF for use in the treatment of neurogenic immune suppression and/or prevention of related medical complications

Wagner, Daniel-Christoph; Pösel, Claudia; Weise, Gesa

Patent

Abstract

The present invention relates to Granulocyte colony-stimulating factor (GCSF) for use in the treatment of neurogenic immune depression syndrome, for use in the prevention of mortality after brain injury and for use in the prevention of brain inflammation after brain injury.

Inventor(s)

Wagner, Daniel-Christoph

Pösel, Claudia

Weise, Gesa

Link to:

Espacenet

Options

GCSF for use in the treatment of neurogenic immune suppression and/or prevention of related medical complications